ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

PMCB PharmaCyte Biotech Inc

2.12
0.00 (0.00%)
30 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
PharmaCyte Biotech Inc PMCB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 2.12 15:55:32
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.12 2.12 2.20 2.12 2.12
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/2/202414:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202408:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/12/202316:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202316:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/11/202315:00EDGAR2Form 8-K - Current report
22/11/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202315:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/11/202307:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
09/11/202316:25EDGAR2Form 8-K - Current report
31/10/202308:15BWPharmaCyte Biotech Provides Corporate Update on..
21/9/202316:04EDGAR2Form S-3/A - Registration statement under Securities Act of..
18/9/202305:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/9/202316:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
11/9/202320:56EDGAR2Form S-3/A - Registration statement under Securities Act of..
07/9/202315:05EDGAR2Form 8-K - Current report
04/8/202315:40EDGAR2Form S-3/A - Registration statement under Securities Act of..
04/8/202315:01EDGAR2Form 8-K - Current report
31/7/202316:18EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
31/7/202315:42EDGAR2Form DEF 14A - Other definitive proxy statements
19/7/202309:28EDGAR2Form PRE 14A - Other preliminary proxy statements
15/6/202308:15BWPharmaCyte Biotech Announces Final Results of Tender Offer
11/5/202307:30BWPharmaCyte Biotech Announces Cash Tender Offer for up to..

Su Consulta Reciente

Delayed Upgrade Clock